NASDAQ: NPCE
Neuropace Inc Stock Ownership - Who owns Neuropace?

Insider buying vs selling

Have Neuropace Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
R. Scott HuennekensDirector2026-11-1812,500$8.29
$103.66kBuy
Joel BeckerCEO2026-11-1711,891$8.35
$99.29kBuy
Patrick F. WilliamsCFO2026-11-1711,891$8.34
$99.15kBuy
Martha MorrellMed2026-09-24335$13.97
$4.68kSell
Patrick F. WilliamsCFO2026-09-201,162$14.28
$16.59kSell
Joel BeckerCEO2026-09-031,310$14.75
$19.32kSell
Martha MorrellMed2026-08-27358$14.13
$5.06kSell
Joel BeckerCEO2026-08-271,126$14.13
$15.91kSell
Martha MorrellCHIEF MEDICAL OFFICER2026-06-24335$16.22
$5.43kSell
Frank M. FischerDirector2026-06-191,467$15.63
$22.93kBuy

1 of 4

NPCE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NPCE insiders and whales buy or sell their stock.

NPCE Shareholders

What type of owners hold Neuropace Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
URI Geiger25.79%8,884,433$72.32MInsider
Greg Shaw Garfield16.41%5,653,237$46.02MInsider
Accelmed Partners II LP12.87%4,432,948$36.08MInsider
Evan Norton11.73%4,042,657$32.91MInsider
Orbimed Advisors LLC10.08%3,473,199$28.27MInsider
Frank M. Fischer1.74%599,534$4.88MInsider
Michael Favet1.25%430,027$3.50MInsider
Joseph Lacob0.69%238,308$1.94MInsider
Joel Becker0.44%149,891$1.22MInsider
Irina Ridley0.41%141,139$1.15MInsider

1 of 3

NPCE vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NPCE0.08%82.30%Net BuyingNet Buying
TMCI0.05%73.54%Net BuyingNet Buying
SSII0.00%100.00%Net BuyingNet Buying
LAB0.07%79.61%Net BuyingNet Buying
OFIX0.10%40.10%Net BuyingNet Buying

Neuropace Stock Ownership FAQ

Who owns Neuropace?

Neuropace (NASDAQ: NPCE) is owned by 0.08% institutional shareholders, 82.30% Neuropace insiders, and 17.63% retail investors. URI Geiger is the largest individual Neuropace shareholder, owning 8.88M shares representing 25.79% of the company. URI Geiger's Neuropace shares are currently valued at $70.63M.

If you're new to stock investing, here's how to buy Neuropace stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.